Clinical Trial Update: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) [Phase 3]

View source ↗

Summary

Phase 3 trial update for Bepirovirsen in nucleos(t)ide analogue–treated chronic hepatitis B patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis B
• Hepatitis B Chronic

Drugs mentioned

• Bepirovirsen

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chronic Hepatitis B, Hepatitis B, Chronic | Phase 3 | Status: COMPLETED